ETS Group Limited — Board/Management Information 2026

Apr 17, 2026

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

ETS GROUP LIMITED

易通訊集團有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 8031)

(I) CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS; (II) CHANGE OF COMPOSITION OF BOARD COMMITTEES; AND (III) COMPLIANCE WITH THE GEM LISTING RULES

CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS

The board (the "Board") of directors (the "Director(s)") of ETS Group Limited (the "Company") announces that Ms. Tsang Lee Mei ("Ms. Tsang") has resigned as an independent non-executive Director with effect from 17 April 2026 as she would like to devote more time to her other business commitments. Ms. Tsang has confirmed that she has no disagreement with the Board and there is no matter in relation to her resignation that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the shareholders of the Company (the "Shareholders").

The Board would like to express its sincere gratitude to Ms. Tsang for her valuable contribution to the Company during her tenure of service.

The Board hereby announces that each of Dr. Xu Weihua (許煥華) ("Dr. Xu") and Mr. Wong Lap Chung (黃立中) ("Mr. Wong") has been appointed as an independent non-executive Director with effect from 17 April 2026. Biographical details of Dr. Xu and Mr. Wong are set out as follows:

Dr. Xu Weihua

Dr. Xu, aged 51, currently acts as a professor of Practice in Accounting and Finance and the Programme Director of the Doctor of Business Artificial Intelligence (DBAI) at The Hong Kong Polytechnic University. His academic background spans civil engineering, psychology, and finance, including an MBA in finance and strategic management from The Wharton School.

---

Before returning to academia, Dr. Xu spent more than 18 years in global financial markets. He founded and managed investment firms as CEO/CIO, overseeing multi-asset portfolios for family offices. He previously worked at JPMorgan Asset Management and Deutsche Bank.

Earlier in his career, Dr. Xu worked in the IT industry, including serving as Senior Manager and CTO of a multinational technology company. He has led system implementation projects, managed cross-border teams, and obtained a range of professional certifications in technology and finance, such as Azure AI, databases, networking, and risk management.

A letter of appointment has been entered into between Dr. Xu and the Company for a term of three years commencing from 17 April 2026, unless terminated by giving one month's prior notice in writing served by the other party or payment of one-month salary in lieu of the said notice. Dr. Xu shall hold office only until the first annual general meeting of the Company after his appointment and shall then be eligible for re-election in accordance with the articles of association (the "Articles") of the Company, and thereafter shall be subject to retirement by rotation and re-election at annual general meeting at least once every three years according to the provisions of the Articles, the Rules (the "GEM Listing Rules") Governing the Listing of Securities on the Stock Exchange and other applicable laws. Dr. Xu is entitled to an annual director's fee of HK$120,000, which is determined with reference to his duties and level of responsibilities, the remuneration policy of the Company and the prevailing market conditions.

Mr. Wong Lap Chung

Mr. Wong, aged 43, has over 20 years of professional experience in the accounting and finance practice. He has held key positions in international professional service firms, including serving as a Senior Tax Consultant at PricewaterhouseCoopers Hong Kong from 2007 to 2010, and as a Tax Manager at KPMG Hong Kong from 2010 to 2012, specialising in tax advisory, compliance, and audit-related matters. Mr. Wong operated a private company, Spectrum Consulting Limited since 2014. The Company provides consulting and taxation services to individual and corporate clients.

Mr. Wong obtained the Bachelor of Business Administration degree from Simon Fraser University in Canada in 2005, majoring in Finance and Accounting. He has been a member of the Hong Kong Institute of Certified Public Accountants since 2010.

A letter of appointment has been entered into between Mr. Wong and the Company for a term of three years commencing from 17 April 2026, unless terminated by giving one month's prior notice in writing served by the other party or payment of one-month salary in lieu of the said notice. Mr. Wong shall hold office only until the first annual general meeting of the Company after his appointment and shall then be eligible for re-election in accordance with the articles of association (the "Articles") of the Company, and thereafter shall be subject to retirement by rotation and re-election at annual general meeting at least once every three years according to the provisions of the Articles, the Rules (the "GEM Listing Rules") Governing the Listing of Securities on the Stock Exchange and other applicable laws. Mr. Wong is entitled to an annual director's fee of HK$120,000, which is determined with reference to his duties and level of responsibilities, the remuneration policy of the Company and the prevailing market conditions.

• 2 -

---

Each of Dr. Xu and Mr. Wong has confirmed that (a) he met the independence criteria as set out in Rule 5.09 of the GEM Listing Rules; (b) he has no past or present financial or other interest in the business of the Company or its subsidiaries or any connection with any core connected person (as defined under the GEM Listing Rules) of the Company; and (c) there are no other factors that may affect his independence at the time of his appointment.

Save as disclosed above, as at the date of this announcement, each of Dr. Xu and Mr. Wong has confirmed that (i) he did not hold any other positions within the Group; (ii) he had no relationship with any Director, member of senior management of the Group or substantial or controlling shareholders (having the meanings ascribed to them in the GEM Listing Rules) of the Company; (iii) did not hold any directorship in public companies the securities of which are listed on any securities market in Hong Kong or overseas in the last three years immediately preceding the date of this announcement; and (iv) did not have, and was not deemed to have, any interests or short positions in any Shares, underlying Shares or debentures of the Company or any of its associated corporations (within the meaning of Part XV of the SFO).

Save as disclosed in this announcement, the Board is not aware of any matter in relation to the appointment of each of Dr. Xu and Mr. Wong that needs to be brought to the attention of the Stock Exchange or the Shareholders nor any information to be disclosed pursuant to Rules 17.50(2)(h) to (v) of the GEM Listing Rules.

The Board would like to take this opportunity to extend its warmest welcome to Dr. Xu and Mr. Wong for joining the Board.

CHANGE OF COMPOSITION OF BOARD COMMITTEES

Following the change of independent non-executive Directors, with effect from 17 April 2026:

(i) Ms. Tsang ceased to be the chairlady of the nomination committee of the Board (the "Nomination Committee") and a member of each of the audit committee of the Board (the "Audit Committee"), the remuneration committee of the Board (the "Remuneration Committee") and the risk management and internal control committee of the Board (the "Risk Management and Internal Control Committee");

(ii) Dr. Xu will be appointed as the chairman of the Nomination Committee and a member of each of the Remuneration Committee, the Audit Committee and the Risk Management and Internal Control Committee; and

(iii) Mr. Wong will be appointed as the chairman of each of the Audit Committee and the Risk Management and Internal Control Committee, and a member of each of the Remuneration Committee and the Nomination Committee.

• 3 -

---

COMPLIANCE WITH THE GEM LISTING RULES

Reference is made to the announcement of the Company dated 31 March 2026 in relation to, among other matters, the non-compliance with Rules 5.05(1) and 5.28 of the GEM Listing Rules.

Following the appointment of Dr. Xu and Mr. Wong, the Company has re-complied with the requirements of Rules 5.05(1) and 5.28 of the GEM Listing Rules.

By order of the Board ETS Group Limited Siu Man On Chairman and Executive Director

Hong Kong, 17 April 2026

As at the date of this announcement, the executive director of the Company is Mr. Siu Man On (Chairman); and the independent non-executive directors of the Company are Ms. Kwong Yuk Ying, Dr. Xu Weihua and Mr. Wong Lap Chung.

This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the GEM Listing Rules for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that to the best of their knowledge and belief, the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive, and there are no other matters the omission of which would make any statement herein or this announcement misleading.

This announcement will remain on the "Latest Listed Company Information" page of the website of the Stock Exchange at www.hkexnews.hk for at least 7 days from the date of its posting and on the Company's website at www.etsgroup.com.hk.

• 4 -